Time is Brain, SL 

We create new solution to adress the best management of Acute Ischemic Stroke

OWNER

Alicia Martínez Piñeiro (See Profile)


Sector

Medical Device

Stage

Prototyping, preclinical

Country

Spain


Patented technology

15% of now considered as non-eligible patients could receive Mechanical Thrombectomy thanks to BraiN20

BraiN20 increases the quality of life of patients who are not eligible today for Mechanical Thrombectomy

BraiN20 reduced time-to-Mechanical Thrombectomy treatment between 60 and 100 minutes

The risk of complications detectable with BraiN20 during Mechanical Thrombectomy treatment is 17.9% and post MT is 5%

IP Type Status Time Countries Link Coverage
Patent Pending
  • Canada
  • France
  • Germany
  • Italy
  • Spain
  • USA
  • United Kingdom
https://patentscope.wipo.int/search/es/detail.jsf?docId=WO2018149973&_cid=P22-KLJWZZ-91074-1 The unique prognostic value of N20 in Mechanical Thrombectomy during hyperacute phase of AIS has been analysed for novelty and non obviousness and Time is Brain (TIB) technology is protected by a patent.

This information is confidential, do not share or copy.

Under evaluation at least till: 15th March

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar